Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

6731 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
89-1 Hyruan ONE LG Chem, Ltd. Original drug imported to China Original drug imported to China The 89th Batch of Reference Listed Drugs
89-2 维泰凯 (VITRAKVI) Bayer AG Original drug imported to China Original drug imported to China The 89th Batch of Reference Listed Drugs
89-3 VITRAKVI (维泰凯) Bayer AG Original drug imported to China Original drug imported to China The 89th Batch of Reference Listed Drugs
89-4 Mounjaro (穆峰达) Eli Lilly and Company Original drug imported to China Original drug imported to China The 89th Batch of Reference Listed Drugs
89-5 Mounjaro (穆峰达) Eli Lilly and Company Original drug imported to China Original drug imported to China The 89th Batch of Reference Listed Drugs
89-6 Mounjaro (穆峰达) Eli Lilly and Company Original drug imported to China Original drug imported to China The 89th Batch of Reference Listed Drugs
89-7 Mounjaro (穆峰达) Eli Lilly and Company Original drug imported to China Original drug imported to China The 89th Batch of Reference Listed Drugs
89-8 Mounjaro Eli Lilly Nederland B.V. Original drug not imported to China Approved in EU The 89th Batch of Reference Listed Drugs
89-9 Mounjaro Eli Lilly Nederland B.V. Original drug not imported to China Approved in EU The 89th Batch of Reference Listed Drugs
89-10 Mounjaro Eli Lilly Nederland B.V. Original drug not imported to China Approved in EU The 89th Batch of Reference Listed Drugs